Deciphera Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2024 | 5 | -$0.64 | -$0.43 | -$0.53 |
| Q3 2024 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q4 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q1 2025 | 2 | -$0.50 | -$0.50 | -$0.50 |
| Q2 2025 | 2 | -$0.47 | -$0.47 | -$0.47 |
| Q3 2025 | 2 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2025 | 2 | -$0.31 | -$0.31 | -$0.31 |
Deciphera Pharmaceuticals, Inc. Earnings Date And Information
Deciphera Pharmaceuticals, Inc. last posted its earnings results on Friday, May 10th, 2024. The company reported $-0.52 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.03. The company had revenue of 45.00 M for the quarter and had revenue of 163.36 M for the year. Deciphera Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.29 diluted earnings per share) and currently has a price-to-earnings ratio of -11.74. Deciphera Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
Deciphera Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/10/2024 | Q1 2024 | -$0.55 | -$0.52 | 0.03 | $46.20 M | $45.00 M |
| 02/07/2024 | Q4 2023 | -$0.54 | $45.93 M | $48.29 M | ||
| 10/30/2023 | Q3 2023 | -$0.60 | -$0.58 | 0.02 | $43.31 M | |
| 08/09/2023 | Q2 2023 | -$0.62 | -$0.57 | 0.05 | $38.30 M | |
| 05/03/2023 | Q1 2023 | -$0.60 | -$0.60 | 0 | $35.69 M | $33.45 M |
| 02/07/2023 | Q4 2022 | -$0.57 | -$0.60 | -0.03 | $35.97 M | $36.35 M |
| 11/03/2022 | Q3 2022 | -$0.57 | -$0.50 | 0.07 | $35.97 M | |
| 08/04/2022 | Q2 2022 | -$0.65 | -$0.58 | 0.07 | $32.49 M | |
| 05/04/2022 | Q1 2022 | -$0.84 | -$0.79 | 0.05 | $26.88 M | $29.22 M |
| 02/08/2022 | Q4 2021 | -$1.49 | -$1.51 | -0.02 | $23.41 M | $24.20 M |
| 11/02/2021 | Q3 2021 | -$1.29 | -$1.37 | -0.08 | $23.22 M | |
| 08/03/2021 | Q2 2021 | -$1.15 | -$1.21 | -0.06 | $23.57 M | |
| 05/04/2021 | Q1 2021 | -$1.08 | -$1.06 | 0.02 | $22.46 M | $25.16 M |
| 02/09/2021 | Q4 2020 | -$1.16 | -$1.11 | 0.05 | $18.65 M | $19.49 M |
| 11/05/2020 | Q3 2020 | -$1.32 | -$1.13 | 0.19 | $15.45 M | |
| 08/04/2020 | Q2 2020 | -$1.34 | -$1.20 | 0.14 | $7.09 M | |
| 05/05/2020 | Q1 2020 | -$1.28 | -$1.36 | -0.08 | $56,985 | $62,000 |
| 03/09/2020 | Q4 2019 | -$1.13 | -$1.31 | -0.18 | $1.25 M | $0 |
| 11/04/2019 | Q3 2019 | -$1.19 | -$1.28 | -0.09 | $0 | |
| 08/02/2019 | Q2 2019 | -$1.06 | -$0.56 | 0.5 | $25.00 M |
Deciphera Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Deciphera Pharmaceuticals, Inc.'s earnings date?
Deciphera Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
-
Did Deciphera Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Deciphera Pharmaceuticals, Inc. (:DCPH) reported $-0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.03.
-
How can I listen to Deciphera Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Deciphera Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Deciphera Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Deciphera Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Deciphera Pharmaceuticals, Inc. generate each year?
Deciphera Pharmaceuticals, Inc. (:DCPH) has a recorded annual revenue of $163.36 M.
-
How much profit does Deciphera Pharmaceuticals, Inc. generate each year?
Deciphera Pharmaceuticals, Inc. (:DCPH) has a recorded net income of $163.36 M. Deciphera Pharmaceuticals, Inc. has generated $-2.29 earnings per share over the last four quarters.
-
What is Deciphera Pharmaceuticals, Inc.'s price-to-earnings ratio?
Deciphera Pharmaceuticals, Inc. (:DCPH) has a price-to-earnings ratio of -11.74 and price/earnings-to-growth ratio is -3.36.
